MiR-613 inhibits the proliferation, migration, and invasion of papillary thyroid carcinoma cells by directly targeting TAGLN2

BACKGROUND: Papillary thyroid carcinoma (PTC), with a rapidly increasing incidence, is the most prevalent malignant cancer of the thyroid. However, its pathogenesis is unclear and its specific clinical indicators have not yet been identified. There is increasing evidence that microRNAs (miRNAs) play...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yonglian, Zhang, Hengwei, Wang, Lidong, Liu, Chenxi, Guo, Mingyue, Tan, Hao, Liu, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447791/
https://www.ncbi.nlm.nih.gov/pubmed/34530821
http://dx.doi.org/10.1186/s12935-021-02083-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447791/
https://www.ncbi.nlm.nih.gov/pubmed/34530821
http://dx.doi.org/10.1186/s12935-021-02083-8

Ejemplares similares